Lab test owner indicted in $100M fraudulent billing scheme

An Arkansas man who owned and managed several diagnostic testing laboratories was indicted in an alleged $100 million fraudulent billing scheme, the Justice Department said Nov. 3. 

Advertisement

Prosecutors allege Billy Joe Taylor and his laboratory testing sites submitted claims for urine drug testing, COVID-19 testing and other clinical tests that were not medically necessary, not ordered by a medical provider or not provided as represented. Further, prosecutors allege Mr. Taylor also obtained medical information for Medicare beneficiaries and misused the information to continually submit claims to Medicare for tests that were not performed by the labs. The alleged scheme took place between February 2017 and May 2021.

Prosecutors claim that as a result of the scheme, the labs owned or managed by Mr. Taylor submitted $100 million in false and fraudulent claims to Medicare.

Mr. Taylor is charged with 16 counts of healthcare fraud and one count of engaging in a monetary transaction in criminally-derived property.

His arraignment is scheduled for Nov. 23. 

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Register to Attend Webinar

Unlocking Structural Heart Capacity: How Leading Programs Use EMR and Data to Improve Patient Flow and Throughput

Wednesday, August 19
11:00 AM - 12:00 PM CDT

Presenters: Katie Kennedy, MSN, APRN, NP-C, Community Heart and VascularMisty Theriot, BSN, RN, CPHQ, FACC, Lake Charles Memorial Health SystemKatie Worthington, DNP, RN, Atlantic Health SystemTaryn Shipley, MBA, CSSBB, Lean HealthTech

Advertisement

Next Up in Lab

Advertisement

Comments are closed.